Abstract

This collection of research illuminates key aspects of pediatric infectious diseases, public health, and clinical management. Studies
cover the efficacy of nirsevimab against RSV, evolving epidemiology of iGAS, and the impact of MIS-C from COVID-19. They also
highlight challenges like antibiotic misuse, alongside successes in meningococcal vaccination and global efforts against congenital
CMV and HIV. Guidelines for septic shock and strategies for vaccine hesitancy are discussed, emphasizing prevention, surveillance,
and improved care to safeguard children’s health against diverse infectious threats and improve outcomes worldwide.